These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 16461183

  • 1. Cardiac consequences of aldosterone excess in human hypertension.
    Rossi GP.
    Am J Hypertens; 2006 Jan; 19(1):10-2. PubMed ID: 16461183
    [No Abstract] [Full Text] [Related]

  • 2. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K, Fujii K, Oniki H, Oka M, Iida M.
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [Abstract] [Full Text] [Related]

  • 3. Left ventricular anatomy and function in primary aldosteronism and renovascular hypertension.
    Pessina AC, Sacchetto A, Rossi GP.
    Adv Exp Med Biol; 1997 Jan; 432():63-9. PubMed ID: 9433512
    [Abstract] [Full Text] [Related]

  • 4. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK, Williams GH.
    Adv Intern Med; 1980 Jan; 25():327-61. PubMed ID: 6153859
    [No Abstract] [Full Text] [Related]

  • 5. [The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension].
    Rubattu S, Volpe M, Raman V, Lindpaintner K.
    Cardiologia; 1997 Jan; 42(1):47-50. PubMed ID: 9118154
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Pathophysiology of left ventricular hypertrophy in arterial hypertension].
    Vallotton MB, Braconi-Quintaje S, Lang U.
    Praxis (Bern 1994); 1997 Feb 11; 86(7):234-7. PubMed ID: 9139339
    [Abstract] [Full Text] [Related]

  • 11. Blood pressure reduction is not the only determinant of outcome.
    Sever PS, Poulter NR, Elliott WJ, Jonsson MC, Black HR, Sever PS, Poulter NR, Elliott WJ, Jonsson MC, Black HR.
    Circulation; 2006 Jun 13; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
    [No Abstract] [Full Text] [Related]

  • 12. Left ventricular hypertrophy in hypertension: etiology, treatment, and controversies.
    Phillips RA, Diamond JA, Gharavi A.
    Mt Sinai J Med; 1998 Mar 13; 65(2):97-103. PubMed ID: 9520512
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacologic probes to identify patients with renovascular hypertension.
    Sosa RE, Vaughan ED.
    Semin Urol; 1985 Nov 13; 3(4):317-24. PubMed ID: 2887024
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Left-ventricular hypertrophy and coronary artery disease.
    Pierdomenico SD.
    Am J Hypertens; 2007 Oct 13; 20(10):1036-7. PubMed ID: 17903684
    [No Abstract] [Full Text] [Related]

  • 17. [The renin-angiotensin system].
    Hilgers KF.
    Urologe A; 2009 Aug 13; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
    [No Abstract] [Full Text] [Related]

  • 18. Pathophysiology and clinical aspects of hypertensive hypertrophy.
    Vogt M, Motz WH, Schwartzkopf B, Strauer BE.
    Eur Heart J; 1993 Jul 13; 14 Suppl D():2-7. PubMed ID: 8103741
    [Abstract] [Full Text] [Related]

  • 19. Calcium antagonism: aldosterone and vascular responses to catecholamines and angiotensin II in man.
    Elliott HL.
    J Hypertens Suppl; 1993 Dec 13; 11(6):S13-6. PubMed ID: 8169376
    [Abstract] [Full Text] [Related]

  • 20. Renin-angiotensin-aldosterone system in hypertension. The clinical usefulness of measuring components of thisystem.
    Ayers CR.
    Va Med Mon (1918); 1969 Jun 13; 96(6):312-4. PubMed ID: 4308355
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.